Here's how the Vanguard Australian Shares Index ETF performed in 2024

Investors in Australia's biggest ASX ETF enjoyed strong returns last year.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Vanguard Australian Shares Index ETF (ASX: VAS) delivered a total gross return of 11.4% in 2024.

This comprised approximately 7.75% in capital growth and a dividend yield of about 3.65%, excluding franking credits, based on preliminary numbers yet to be confirmed by Vanguard.

The VAS exchange-traded fund (ETF) closed at $101.73 per unit on 31 December.

The ETF hit a 52-week high of $105.94 on 3 December, which was the same day that the benchmark S&P/ASX 200 Index (ASX: XJO) recorded a new all-time peak of 8,514.5 points.

With $17.69 billion in funds under management, the Vanguard Australian Shares Index ETF is the largest ETF by market cap on the ASX.

It gives investors exposure to the 300 largest companies on the Australian share market. It seeks to track the performance of the S&P/ASX 300 Index (ASX: XKO) before fees.

The inclusion of 100 small-cap shares ranked between 201 and 300 gives the VAS ETF a point of difference to the many ASX ETFs that track the benchmark ASX 200 alone.

This can be advantageous or disadvantageous depending on the market conditions each year.

In 2024, there was a negligible difference in performance between the ASX 200 and ASX 300.

The ASX 200 delivered a total gross return of 11.44% and the ASX 300 dished up an 11.39% return.

The tide may turn in the new year, though, as falling interest rates are typically a tailwind for smaller growth companies.

The US Federal Reserve cut interest rates in the world's biggest economy three times in the second half of 2024. The US rate range is now 4.25% to 4.5%, which brings it closer to the Australian cash rate of 4.35%.

Economists anticipate that the Reserve Bank will begin cutting rates in Australia in the first half of 2025.

In reviewing the Vanguard Australian Shares Index ETF's 2024 performance, we identified the shares that rose the most among its basket of 300 stocks. Check them out below.

10 strongest risers within the VAS ETF in 2024

1Mesoblast Ltd (ASX: MSB)

ASX 300 biotech share Mesoblast was the biggest mover within the Vanguard Australian Shares Index ETF.

The Mesoboast share price zoomed 900% higher to finish the year at $3.10.

2. Zip Co Ltd (ASX: ZIP)

This ASX 300 financial share gained an astonishing 362.5% in value to close the year at $2.96.

3. IperionX Ltd (ASX: IPX)

This ASX 300 materials share soared 295.68% to $5.50 per share in 2024.

4. Nuix Limited (ASX: NXL

The Nuix share price rocketed 232.63% to close out the year at $6.32.

5. Superloop Ltd (ASX: SLC)

Shares in ASX telecommunications company SuperLoop streaked 226.87% higher to $2.19.

6. Life360 Inc (ASX: 360)

Stock in social tracking app developer Life360 rose by 198.15% to finish at $22.54 on 31 December.

7. Spartan Resources Ltd (ASX: SPR)

The Spartan Resources share price rose by 171.15% to finish the year at $1.41.

8. Sigma Healthcare Ltd (ASX: SIG)

ASX healthcare share Sigma ripped 162% higher to close at $2.62 on 31 December.

9. Pro Medicus Limited (ASX: PME)

The Pro Medicus share price rose by 161% to finish at $250.12 per share.

10. Telix Pharmaceuticals Ltd (ASX: TLX)

The Telix Pharmaceuticals share price lifted 144.14% to close at $24.61 on 31 December.

Should you invest $1,000 in Mesoblast Limited right now?

Before you buy Mesoblast Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Mesoblast Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Bronwyn Allen has positions in Mesoblast and Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Telix Pharmaceuticals, and Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Nuix, Pro Medicus, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
ETFs

Meet these two new ASX ETFs

Two new ETFs are set to join the ASX.

Read more »

Happy young couple saving money in piggy bank.
ETFs

3 ASX ETFs to buy for lifelong income

These funds could provide passive income investors with regular paychecks.

Read more »

A woman sits at her desk thinking. She is surrounded by projections of world maps on various screens with data appearing below them.
ETFs

Here's 1 ASX ETF that I'd happily make my entire portfolio

This fund offers both diversification and growth.

Read more »

a business person checks his mobile phone outside a Wall Street office with an American flag and other business people in the background.
ETFs

How to choose a US focused ASX ETF for the current market environment

Here are 5 US focused ASX ETFs to consider.

Read more »

ETF in blue with person's hand in the direction of green and red bars on graph.
ETFs

Bargain hunting: Which ASX ETFs have fallen the most in 2025?

Looking for ETFs that could be undervalued after a rocky 2025? Here are three options to consider.

Read more »

Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
ETFs

Where I'd invest $5,000 in ASX ETFs after the selloff

Let's see which funds could be top picks for an investment right now.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
ETFs

10 ASX ETFs to buy after the Easter break

There's something for everyone with these funds. Let's take a look at them.

Read more »

Woman and man calculating a dividend yield.
ETFs

Trade war heats up: Which ASX ETFs are most exposed to China?

These China-focused funds could be in the firing line.

Read more »